Status:
COMPLETED
Artificial Intelligence - SARS-CoV-2 (COVID-19) Risk Evaluation
Lead Sponsor:
IRCCS San Raffaele
Collaborating Sponsors:
Regione Lombardia
Orobix Srl
Conditions:
Covid19
Eligibility:
All Genders
18-100 years
Brief Summary
The management of COVID-19 patients in overwhelmed hospital facing the pandemic is a clinical challenge. The improvement of decision making may allow a better allocation of available resources and a ...
Eligibility Criteria
Inclusion
- confirmed SARS-CoV-2 infection with RT-PCR
- non contrast chest CT scan performed within 72 hours after admission to the emergency department
Exclusion
- age \< 18 ys
Key Trial Info
Start Date :
February 16 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2021
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT04834934
Start Date
February 16 2020
End Date
June 30 2021
Last Update
May 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS San Raffaele
Milan, Italy, 20132